Skip to content

Drug interactions

Ticagrelor + Tipranavir

Severity: Major

Ticagrelor and Tipranavir: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tipranavir, given with ritonavir, inhibits CYP3A4 and may greatly increase ticagrelor levels, raising bleeding risk. Tipranavir also has inducing effects, making the net effect less predictable.

What this interaction means in plain words

Ticagrelor and Tipranavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ticagrelor belongs to Cardiovascular; Tipranavir belongs to Anti Virals.

Evidence level: Low

Why it happens

Ritonavir-boosted tipranavir inhibits CYP3A4 and reduces ticagrelor clearance.

What to do

Avoid the combination; use an alternative P2Y12 inhibitor or antiretroviral regimen. If unavoidable, monitor closely for bleeding.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ticagrelor and Tipranavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ticagrelor with Tipranavir?

MediHelp rates the interaction as major. Ticagrelor and Tipranavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tipranavir, given with ritonavir, inhibits CYP3A4 and may greatly increase ticagrelor levels, raising bleeding risk. Tipranavir also has inducing effects, making the net effect less predictable.

How serious is the interaction between Ticagrelor and Tipranavir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; use an alternative P2Y12 inhibitor or antiretroviral regimen. If unavoidable, monitor closely for bleeding.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in